Evidence map›Paper›PMID 29208764›Full record

ReviewBioscience reports2018

Thiamine and selected thiamine antivitamins - biological activity and methods of synthesis.

Adam Tylicki, Zenon Łotowski, Magdalena Siemieniuk, Artur Ratkiewicz

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07450833 (Assessing the Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine), which is not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07450833 phase1completednot on this mapstarted 2022, after this paper: background citation

Assessing the Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers - An Open Label, Phase I Study

TypeinterventionalSponsorBenfovir AGRan2022 to 2022Enrolled48ConditionsHealthy VolunteersArmsBenfo-oxythiamine
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Simultaneous Determination of the BInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Regulation of and challenges in targeting NADNature reviews. Molecular cell biology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Adam TylickiDepartment of Cytobiochemistry, Faculty of Biology and Chemistry, University of Bialystok, Ciolkowskiego 1J, 15-245 Białystok, Poland.
Zenon ŁotowskiDepartment of Natural Product Chemistry, Faculty of Biology and Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Białystok, Poland zlch@uwb.edu.pl.
Magdalena SiemieniukDepartment of Cytobiochemistry, Faculty of Biology and Chemistry, University of Bialystok, Ciolkowskiego 1J, 15-245 Białystok, Poland.
Artur RatkiewiczDepartment of Theoretical Chemistry, Faculty of Biology and Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Białystok, Poland.
University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thiamine plays a very important coenzymatic and non-coenzymatic role in the regulation of basic metabolism. Thiamine diphosphate is a coenzyme of many enzymes, most of which occur in prokaryotes. Pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes as well as transketolase are the examples of thiamine-dependent enzymes present in eukaryotes, including human. Therefore, thiamine is considered as drug or diet supplement which can support the treatment of many pathologies including neurodegenerative and vascular system diseases. On the other hand, thiamine antivitamins, which can interact with thiamine-dependent enzymes impeding their native functions, thiamine transport into the cells or a thiamine diphosphate synthesis, are good propose to drug design. The development of organic chemistry in the last century allowed the synthesis of various thiamine antimetabolites such as amprolium, pyrithiamine, oxythiamine, or 3-deazathiamine. Results of biochemical and theoretical chemistry research show that affinity to thiamine diphosphate-dependent enzymes of these synthetic molecules exceeds the affinity of native coenzyme. Therefore, some of them have already been used in the treatment of coccidiosis (amprolium), other are extensively studied as cytostatics in the treatment of cancer or fungal infections (oxythiamine and pyrithiamine). This review summarizes the current knowledge concerning the synthesis and mechanisms of action of selected thiamine antivitamins and indicates the potential of their practical use.

Indexed as

Drug DesignAmproliumAntimetabolitesBiological TransportHumansOxythiaminePyrithiamineThiamineThiamine PyrophosphateAmproliumAntimetabolitesOxythiaminePyrithiamineThiamineThiamine Pyrophosphate3-deazathiamineamproliumoxythiaminepyrithiaminethiamine

Identifiers

PMID29208764
PMCPMC6435462
OpenAlexW2771191714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.